Keratin, Type II Cytoskeletal 8 (KRT8) Antibody

Este producto es parte de KRT8 - Keratin 8 (Cytokeratin 8)
Product Graph
299€ (0.1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Keratin, Type II Cytoskeletal 8 (KRT8) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx139677
tested applications
WB, IHC, IF/ICC, IP

Description

Cytokeratin 8 Antibody is a Mouse Monoclonal against Cytokeratin 8.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Keratin, Type II Cytoskeletal 8 (KRT8)
Host
Mouse
Reactivity
Human, Pig, Cow, Sheep
Recommended Dilution
Validated in IHC-P and ICC. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1
Clone ID
C110
Purity
> 95% (SDS-PAGE)
Purification
Purified by Protein A affinity chromatography.
Size 1
0.1 mg
Tested Applications
WB, IHC, IF/ICC, IP
Buffer
PBS solution with 15 mM sodium azide.
Availability
Shipped within 5-12 working days.
Storage
Store at 2-8°C. Do not freeze.
Dry Ice
No
UniProt ID
Q7L4M3
Gene ID
3856
Alias
K8,KO,CK8,CK-8,CYK8,K2C8,CARD2,Cytokeratin-8,Keratin-8,Type-II keratin Kb8
Background
Antibody anti-KRT8
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

Keratin 8 (KRT8) is a type II intermediate filament protein primarily expressed in simple epithelial tissues, including the gastrointestinal tract, liver, and lungs, where it provides mechanical support and structural stability to epithelial cells KRT8 pairs with keratin 18 (KRT18) to form heterodimers that assemble into intermediate filaments, maintaining cytoskeletal integrity and cell resilience under mechanical and chemical stress KRT8 is involved in cell signaling, apoptosis, and protection against oxidative stress, contributing to epithelial cell survival Dysregulation or mutations in KRT8 are associated with liver diseases such as steatohepatitis, cirrhosis, and hepatocellular carcinoma, where KRT8 aggregates can impair cellular function KRT8 also participates in tumorigenesis by promoting epithelial-mesenchymal transition (EMT), enhancing cancer cell migration, invasion, and metastasis Elevated KRT8 expression is observed in various cancers, including colorectal, breast, and pancreatic cancer, where it serves as a diagnostic marker for disease progression and prognosis

Related Products

P4525

Recombinant Human KRT8

Ver Producto
abx000965

Keratin, Type II Cytoskeletal 8 (KRT8) Antibody

KRT8 Antibody is a Rabbit Polyclonal antibody against KRT8. This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene.

Ver Producto
abx010621

Keratin, Type II Cytoskeletal 8 (KRT8) Antibody

Cytokeratin 8, also known as CK8, KRT8, K8. Entrez Protein NP002264. It is a member of the type II keratin family.Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells.It typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis.

Ver Producto